IL13Rα2-targeted CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL13Rα2-targeted CAR T cells, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children [Phase 1]